Mevacor and Pancreatitis - a phase IV clinical study of FDA data
Summary:
Pancreatitis is found among people who take Mevacor, especially for people who are male, 60+ old.
The phase IV clinical study analyzes which people take Mevacor and have Pancreatitis. It is created by eHealthMe based on reports of 4,850 people who have side effects when taking Mevacor from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
4,850 people reported to have side effects when taking Mevacor.
Among them, 33 people (0.68%) have Pancreatitis.
What is Mevacor?
Mevacor has active ingredients of lovastatin. It is often used in high blood cholesterol. eHealthMe is studying from 4,921 Mevacor users for its effectiveness, alternative drugs and more.
What is Pancreatitis?
Pancreatitis (inflammation of pancreas) is found to be associated with 2,795 drugs and 1,968 conditions by eHealthMe.
Number of Mevacor and Pancreatitis reports submitted per year:

Gender of people who have Pancreatitis when taking Mevacor *:
- female: 43.33 %
- male: 56.67 %
Age of people who have Pancreatitis when taking Mevacor *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 3.57 %
- 40-49: 7.14 %
- 50-59: 35.71 %
- 60+: 53.57 %
Common drugs people take besides Mevacor *:
- Aspirin: 10 people, 30.30%
- Prilosec: 9 people, 27.27%
- Byetta: 7 people, 21.21%
- Percocet: 6 people, 18.18%
- Lovastatin: 6 people, 18.18%
- Dilaudid: 5 people, 15.15%
- Lisinopril: 5 people, 15.15%
- Atenolol: 5 people, 15.15%
- Lopressor: 5 people, 15.15%
- Glucotrol: 5 people, 15.15%
Common side effects people have besides Pancreatitis *:
- Blood Urea Increased: 6 people, 18.18%
- Nausea (feeling of having an urge to vomit): 5 people, 15.15%
- Haemoglobin Decreased: 5 people, 15.15%
- Pancreatitis Necrotising (inflammation of the pancreas cause death of tissue in pancreas): 5 people, 15.15%
- Pancreatitis Acute (sudden inflammation of pancreas): 5 people, 15.15%
- Renal Failure Acute (rapid kidney dysfunction): 4 people, 12.12%
- Anion Gap Increased: 4 people, 12.12%
- Abdominal Distension: 4 people, 12.12%
- Urine Output - Decreased: 4 people, 12.12%
- Diabetes: 4 people, 12.12%
Common conditions people have *:
- Type 2 Diabetes: 3 people, 9.09%
- Diabetes: 3 people, 9.09%
- Stress And Anxiety: 2 people, 6.06%
- Depression: 2 people, 6.06%
- Growth Of Eyelashes: 1 person, 3.03%
- Blood Glucose Increased: 1 person, 3.03%
- Bone Disorder: 1 person, 3.03%
- Breathing Difficulty: 1 person, 3.03%
- Eye Disorder: 1 person, 3.03%
- Gastric Ulcer (stomach ulcer): 1 person, 3.03%
* Approximation only. Some reports may have incomplete information.
Do you take Mevacor and have Pancreatitis?
Check whether Pancreatitis is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Sirkeci, ?., Sirkeci, E. E., & Ta?el, B. , "Rivaroxaban-induced acute pancreatitis", The European Research Journal, 2018 Jan .
- Liao, K. F., Huang, P. T., Lin, C. C., Lin, C. L., & Lai, S. W., "Fluvastatin use and risk of acute pancreatitis: a population-based case-control study in Taiwan", Biomedicine, 2014 Jan .
- Arshad F, Ladakhi Y, Khan MA, "A rare case of carbamazepine induced pancreatitis", International Journal of Students’ Research, 2013 Jul .
- Das S, Mondal S, Dey JK, Bandyopadhyay S, Saha I, Tripathi SK, "A case of montelukast induced hypercholesterolemia, severe hypertriglyceridemia and pancreatitis", Journal of Young Pharmacists, 2013 Jun .
Related studies
How severe was Pancreatitis and when was it recovered:
Expand to all the drugs that have ingredients of lovastatin:
- Pancreatitis and drugs with ingredients of lovastatin (218 reports)
Alternative drugs to, pros and cons of Mevacor:
- Mevacor (4,921 reports)
Common Mevacor side effects:
- Weakness: 393 reports
- Drug ineffective: 344 reports
- Fatigue (feeling of tiredness): 317 reports
- Muscle aches (muscle pain): 313 reports
- Pain: 311 reports
- Breathing difficulty: 295 reports
- Heart attack: 240 reports
- Stress and anxiety: 226 reports
Browse all side effects of Mevacor:
a b c d e f g h i j k l m n o p q r s t u v w x y zPancreatitis treatments and more:
- Pancreatitis (56,682 reports)
COVID vaccines that are related to Pancreatitis:
- Pancreatitis in Moderna COVID Vaccine
- Pancreatitis in Pfizer BioNTech Covid Vaccine
- Pancreatitis in Johnson and Johnson Covid Vaccine
Common drugs associated with Pancreatitis:
- Seroquel: 4,892 reports
- Metformin: 4,060 reports
- Byetta: 3,275 reports
- Januvia: 2,572 reports
- Zyprexa: 2,458 reports
- Prednisone: 2,450 reports
- Victoza: 2,301 reports
- Aspirin: 2,217 reports
- Lisinopril: 2,105 reports
- Methotrexate: 1,964 reports
All the drugs that are associated with Pancreatitis:
- Pancreatitis (2,795 drugs)
Common conditions associated with Pancreatitis:
- Type 2 diabetes: 5,528 reports
- Diabetes: 3,048 reports
- High blood pressure: 2,706 reports
- Depression: 2,134 reports
- Rheumatoid arthritis: 1,792 reports
All the conditions that are associated with Pancreatitis:
- Pancreatitis (1,968 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on lovastatin (the active ingredients of Mevacor) and Mevacor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Levocarnitine and Hot Flush - 3 seconds ago
- Levocarnitine and Confusion - 3 seconds ago
- Levetiracetam and Urticaria - 6 seconds ago
- Levocarnitine and Anhedonia - 7 seconds ago
- Levetiracetam and Tachypnea - 7 seconds ago
- Levetiracetam and Deformity - 9 seconds ago
- Nitroglycerin and Vitreous Floaters - 9 seconds ago
- Acute Kidney Failure and Aortic Stenosis - 13 seconds ago
- Levetiracetam and Catatonia - 14 seconds ago
- Levetiracetam and Bone Pain - 14 seconds ago